DSO, D. E. S., LJ, C., AS, R., Á, L., JPC, S., GM, F., . . . EF, B. (2023). Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein. Virology journal, 20(1), 304. https://doi.org/10.1186/s12985-023-02264-z
Chicago Style (17th ed.) CitationDSO, Daian E Silva, et al. "Preclinical Assessment of an Anti-HTLV-1 Heterologous DNA/MVA Vaccine Protocol Expressing a Multiepitope HBZ Protein." Virology Journal 20, no. 1 (2023): 304. https://doi.org/10.1186/s12985-023-02264-z.
MLA (9th ed.) CitationDSO, Daian E Silva, et al. "Preclinical Assessment of an Anti-HTLV-1 Heterologous DNA/MVA Vaccine Protocol Expressing a Multiepitope HBZ Protein." Virology Journal, vol. 20, no. 1, 2023, p. 304, https://doi.org/10.1186/s12985-023-02264-z.